About Hepa Pharma
Hepa Pharma is a Technology company based in Hyderabad (India) founded in 2020. It delivers comprehensive API development services for clients. It operates on a B2B model. The company has 1 employees. Its Indian entity Hepa Pharma Private Limited reported revenue of ₹19.94 Cr. Its focus areas include Software Development, API Services and Custom Solutions. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Hepa Pharma, established in 2020, excels in leveraging cutting-edge technology, creating custom software solutions, api services, and custom solutions. Delivers comprehensive API development services for clients. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
- Headquarters Hyderabad, India
- Employees 1
- SectorsTechnology
- Website hepapharma.com
- Legal Name Hepa Pharma Private Limited
- Date of Incorporation 10 Aug, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹19.94 Cr
FY 2024 · +267% YoY
- Net Profit₹1.09 Cr
FY 2024 · 5% margin
- EBITDA₹1.57 Cr
FY 2024 · 8% margin
- Employee Count1
Associated legal entities of Hepa Pharma
Hepa Pharma operates through Hepa Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Hepa Pharma Private Limited CIN U24100TG2020PTC142664 | Active | 10 Aug 2020 | Hyderabad, Telangana | ₹19.9 Cr | 2 | View details |
Board of directors of Hepa Pharma Private Limited (Hepa Pharma)
Hepa Pharma Private Limited is the primary company behind Hepa Pharma. The board of Hepa Pharma Private Limited currently have 2 directors; the longest-serving is Venkateswara Rao Yarrabathina, appointed in 2021. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkateswara Rao Yarrabathina DIN 09304438 | Additional Director | 04 Sep 2021 | 5 yrs 1 mo | Hepa Pharma Private Limited |
| Sudheer Kumar Darapureddi DIN 10733121 | Additional Director | 09 Aug 2024 | 2 yrs 2 mo | Hepa Pharma Private Limited |
Financials of Hepa Pharma
Figures of Hepa Pharma Private Limited, the primary company behind Hepa Pharma, for FY 2024. Revenue was ₹19.94 Cr (+267% year on year). Net profit was ₹1.09 Cr (5% margin). EBITDA was ₹1.57 Cr (8% margin). Revenue has grown at a compounded annual rate of -4% over three years.
- ₹19.94 CrRevenue · FY 2024 · +267% YoY
- ₹1.09 CrNet profit · 5% margin
- ₹1.57 CrEBITDA · 8% margin
- ₹1 LakhPaid-up capital
- -4%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Hepa Pharma Private Limited are on its company page.
Detailed financial statements for Hepa Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Hepa Pharma
Hepa Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Hepa Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Hepa Pharma
Hepa Pharma was founded in 2020.
Hepa Pharma is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Hepa Pharma has 1 employees.
The primary company behind Hepa Pharma, Hepa Pharma Private Limited, reported revenue of ₹19.94 Cr for FY 2024, up 267% year on year.
Hepa Pharma, established in 2020, excels in leveraging cutting-edge technology, creating custom software solutions, api services, and custom solutions. Delivers comprehensive API development services for clients. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide.
Hepa Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Hepa Pharma operates through Hepa Pharma Private Limited.
The legal entities of Hepa Pharma currently have 2 directors, including Venkateswara Rao Yarrabathina, Sudheer Kumar Darapureddi.